Accordingly, the reduced NIS mRNA levels and/or impairment in NIS plasma membrane trafficking are well-demonstrated factors showing poor prognosis in thyroid cancer [15]. This evidence concerns the gene SLC5A5 and thyroid gland carcinoma.